ESPEN guideline on clinical nutrition in liver disease

Published:January 16, 2019DOI:https://doi.org/10.1016/j.clnu.2018.12.022

      Summary

      This update of evidence-based guidelines (GL) aims to translate current evidence and expert opinion into recommendations for multidisciplinary teams responsible for the optimal nutritional and metabolic management of adult patients with liver disease. The GL was commissioned and financially supported by ESPEN. Members of the guideline group were selected by ESPEN.
      We searched for meta-analyses, systematic reviews and single clinical trials based on clinical questions according to the PICO format. The evidence was evaluated and used to develop clinical recommendations implementing the SIGN method.
      A total of 85 recommendations were made for the nutritional and metabolic management of patients with acute liver failure, severe alcoholic steatohepatitis, non-alcoholic fatty liver disease, liver cirrhosis, liver surgery and transplantation as well as nutrition associated liver injury distinct from fatty liver disease. The recommendations are preceded by statements covering current knowledge of the underlying pathophysiology and pathobiochemistry as well as pertinent methods for the assessment of nutritional status and body composition.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Nutrition
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Patek A.J.
        • Post J.
        Treatment of cirrhosis of the liver by a nutritious diet and supplements rich in vitamin B complex.
        J Clin Invest. 1941; 20: 481-505
        • Child C.G.T.J.
        Surgery and portal hypertension.
        in: CG C. The liver and portal hypertension. Saunders, Philadelphia1964: 50-51
        • Plauth M.
        • Merli M.
        • Kondrup J.
        • Weimann A.
        • Ferenci P.
        • Müller M.
        • et al.
        ESPEN guidelines for nutrition in liver disease and transplantation.
        Clin Nutr. 1997; 16: 43-55
        • Plauth M.
        • Cabre E.
        • Riggio O.
        • Assis-Camilo M.
        • Pirlich M.
        • Kondrup J.
        • et al.
        ESPEN guidelines on enteral nutrition: liver disease.
        Clin Nutr. 2006; 25: 285-294
        • Plauth M.
        • Cabre E.
        • Campillo B.
        • Kondrup J.
        • Marchesini G.
        • Schütz T.
        • et al.
        ESPEN guidelines on parenteral nutrition: hepatology.
        Clin Nutr. 2009; 28: 436-444
        • Bischoff S.C.
        • Singer P.
        • Koller M.
        • Barazzoni R.
        • Cederholm T.
        • van Gossum A.
        Standard operating procedures for ESPEN guidelines and consensus papers.
        Elsevier, 2015
        • Plauth M.
        • Schütz T.
        • Pirlich M.
        • Canbay A.
        • Committee d.D.S.
        S3-Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) in Zusammenarbeit mit der GESKES, der AKE und der DGVS.
        Aktuelle Ernährungsmedizin. 2014; 39: e1-e42
        • Scottish Intercollegiate Guidelines Network (SIGN)
        SIGN 50: a guideline developer's handbook. Revised version.
        SIGN, Edinburgh2014
        • Koller M.
        • Schütz T.
        • Valentini L.
        • Kopp I.
        • Pichard C.
        • Lochs H.
        • et al.
        Outcome models in clinical studies: implications for designing and evaluating trials in clinical nutrition.
        Clin Nutr. 2013; 32: 650-657
        • German Association of the Scientific Medical Societies (AWMF)
        • Standing Guidelines Commission
        AWMF guidance manual and rules for guideline development.
        1st ed. 2012 ([English version])
        • Lautz H.
        • Selberg O.
        • Körber J.
        • Bürger M.
        • Müller M.
        Protein-calorie malnutrition in liver cirrhosis.
        Clin Invest. 1992; 70: 478-486
        • Mendenhall C.L.
        • Anderson S.
        • Weesner R.E.
        • Goldberg S.J.
        • Crolic K.A.
        Protein-calorie malnutrition associated with alcoholic hepatitis: veterans administration cooperative study group on alcoholic hepatitis.
        Am J Med. 1984; 76: 211-222
        • Cirrhosis NSi
        Italian multicentre cooperative project on nutrition in liver cirrhosis.
        J Hepatol. 1994; 21: 317-325
        • Peng S.
        • Plank L.D.
        • McCall J.L.
        • Gillanders L.K.
        • McIlroy K.
        • Gane E.J.
        Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study.
        Am J Clin Nutr. 2007; 85: 1257-1266
        • Prijatmoko D.
        • Strauss B.J.
        • Lambert J.R.
        • Sievert W.
        • Stroud D.B.
        • Wahlqvist M.L.
        • et al.
        Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis.
        Gastroenterology. 1993; 105: 1839-1845
        • Selberg O.
        • Böttcher J.
        • Pirlich M.
        • Henkel E.
        • Manns M.P.
        • Müller M.J.
        Clinical significance and correlates of whole body potassium status in patients with liver cirrhosis.
        Hepatol Res. 1999; 16: 36-48
        • Mills P.R.
        • Shenkin A.
        • Anthony R.S.
        • McLelland A.S.
        • Main A.
        • MacSween R.
        • et al.
        Assessment of nutritional status and in vivo immune responses in alcoholic liver disease.
        Am J Clin Nutr. 1983; 38: 849-859
      1. Schenker S. Halff G.A. Nutritional therapy in alcoholic liver disease. Semin Liver Dis, 1993
        • Lieber C.S.
        Alcohol, liver, and nutrition.
        J Am Coll Nutr. 1991; 10: 602-632
      2. Lindor K.D. Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis. Semin Liver Dis, 1993
        • Sam J.
        • Nguyen G.C.
        Protein–calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension.
        Liver Int. 2009; 29: 1396-1402
        • Alberino F.
        • Gatta A.
        • Amodio P.
        • Merkel C.
        • Di Pascoli L.
        • Boffo G.
        • et al.
        Nutrition and survival in patients with liver cirrhosis.
        Nutrition. 2001; 17: 445-450
        • Selberg O.
        • Selberg D.
        Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis.
        Eur J Appl Physiol. 2002; 86: 509-516
        • DiMartini A.
        • Cruz Jr., R.J.
        • Dew M.A.
        • Myaskovsky L.
        • Goodpaster B.
        • Fox K.
        • et al.
        Muscle mass predicts outcomes following liver transplantation.
        Liver Transplant. 2013; 19: 1172-1180
        • Harrison J.
        • McKiernan J.
        • Neuberger J.M.
        A prospective study on the effect of recipient nutritional status on outcome in liver transplantation.
        Transpl Int. 1997; 10: 369-374
        • Moukarzel A.A.
        • Najm I.
        • Vargas J.
        • McDiarmid S.V.
        • Busuttil R.W.
        • Ament M.E.
        Effect of nutritional status on outcome of orthotopic liver transplantation in pediatric patients.
        Transplant Proc. 1990; 22: 1560-1563
        • Pikul J.
        • Sharpe M.D.
        • Lowndes R.
        • Ghent C.N.
        Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients.
        Transplantation. 1994; 57: 469-472
        • Figueiredo F.
        • Dickson E.R.
        • Pasha T.
        • Kasparova P.
        • Therneau T.
        • Malinchoc M.
        • et al.
        Impact of nutritional status on outcomes after liver transplantation.
        Transplantation. 2000; 70: 1347-1352
        • Kalafateli M.
        • Mantzoukis K.
        • Choi Yau Y.
        • Mohammad A.O.
        • Arora S.
        • Rodrigues S.
        • et al.
        Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the model for end-stage liver disease score.
        J Cachexia Sarcopenia Muscle. 2017; 8: 113-121
        • Dharancy S.
        • Lemyze M.
        • Boleslawski E.
        • Neviere R.
        • Declerck N.
        • Canva V.
        • et al.
        Impact of impaired aerobic capacity on liver transplant candidates.
        Transplantation. 2008; 86: 1077-1083
        • Selberg O.
        • Bottcher J.
        • Tusch G.
        • Pichlmayr R.
        • Henkel E.
        • Muller M.J.
        Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients.
        Hepatology. 1997; 25: 652-657
        • Epstein S.K.
        • Freeman R.B.
        • Khayat A.
        • Unterborn J.N.
        • Pratt D.S.
        • Kaplan M.M.
        Aerobic capacity is associated with 100-day outcome after hepatic transplantation.
        Liver Transplant. 2004; 10: 418-424
        • Muller M.J.
        • Lautz H.U.
        • Plogmann B.
        • Burger M.
        • Korber J.
        • Schmidt F.W.
        Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state.
        Hepatology. 1992; 15: 782-794
        • Englesbe M.J.
        • Patel S.P.
        • He K.
        • Lynch R.J.
        • Schaubel D.E.
        • Harbaugh C.
        • et al.
        Sarcopenia and mortality after liver transplantation.
        J Am Coll Surg. 2010; 211: 271-278
        • Clemmesen J.O.
        • Kondrup J.
        • Ott P.
        Splanchnic and leg exchange of amino acids and ammonia in acute liver failure.
        Gastroenterology. 2000; 118: 1131-1139
        • Record C.
        • Buxton B.
        • Chase R.
        • Curzon G.
        • Murray-Lyon I.
        • Williams R.
        Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy.
        Eur J Clin Invest. 1976; 6: 387-394
        • Rosen H.M.
        • Yoshimura N.
        • Hodgman J.M.
        • Fischer J.E.
        Plasma amino acid patterns in hepatic encephalopathy of differing etiology.
        Gastroenterology. 1977; 72: 483-487
      3. Bernuau J. Rueff B. Benhamou J.-P. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis, 1986
        • Samson R.
        • Trey C.
        • Timme A.
        • Saunders S.
        Fulminating hepatitis with recurrent hypoglycemia and hemorrhage.
        Gastroenterology. 1967; 53: 291-&
        • Vilstrup H.
        • Iversen J.
        • Tygstrup N.
        Glucoregulation in acute liver failure.
        Eur J Clin Invest. 1986; 16: 193-197
        • Clemmesen J.O.
        • Høy C.-E.
        • Kondrup J.
        • Ott P.
        Splanchnic metabolism of fuel substrates in acute liver failure.
        J Hepatol. 2000; 33: 941-948
        • Owen O.E.
        • Reichle F.A.
        • Mozzoli M.A.
        • Kreulen T.
        • Patel M.S.
        • Elfenbein I.B.
        • et al.
        Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis.
        J Clin Invest. 1981; 68: 240-252
        • Owen O.
        • Trapp V.
        • Reichard G.
        • Mozzoli M.
        • Moctezuma J.
        • Paul P.
        • et al.
        Nature and quantity of fuels consumed in patients with alcoholic cirrhosis.
        J Clin Invest. 1983; 72: 1821-1832
        • Müller M.J.
        • Willmann O.
        • Rieger A.
        • Fenk A.
        • Selberg O.
        • Lautz H.U.
        • et al.
        Mechanism of insulin resistance associated with liver cirrhosis.
        Gastroenterology. 1992; 102: 2033-2041
        • Selberg O.
        • Burchert W.
        • Vd Hoff J.
        • Meyer G.J.
        • Hundeshagen H.
        • Radoch E.
        • et al.
        Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism.
        J Clin Invest. 1993; 91: 1897-1902
        • Kruszynska Y.
        • Williams N.
        • Perry M.
        • Home P.
        The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis.
        Hepatology. 1988; 8: 1615-1619
        • Selberg O.
        • Radoch E.
        • Walter G.F.
        • Müller M.J.
        Skeletal muscle glycogen content in patients with cirrhosis.
        Hepatology. 1994; 20: 135-141
        • Bianchi G.
        • Marchesini G.
        • Zoli M.
        • Bugianesi E.
        • Fabbri A.
        • Pisi E.
        Prognostic significance of diabetes in patients with cirrhosis.
        Hepatology. 1994; 20: 119-125
        • Müller M.
        • Pirlich M.
        • Balks H.
        • Selberg O.
        Glucose intolerance in liver cirrhosis: role of hepatic and non-hepatic influences.
        Clin Chem Lab Med. 1994; 32: 749-758
        • Kalaitzakis E.
        • Olsson R.
        • Henfridsson P.
        • Hugosson I.
        • Bengtsson M.
        • Jalan R.
        • et al.
        Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.
        Liver Int. 2007; 27: 1194-1201
        • Merli M.
        • Eriksson L.S.
        • Hagenfeldt L.
        • Wahren J.
        Splanchnic and leg exchange of free fatty acids in patients with liver cirrhosis.
        J Hepatol. 1986; 3: 348-355
        • Merli M.
        • Riggio O.
        • Romiti A.
        • Ariosto F.
        • Mango L.
        • Pinto G.
        • et al.
        Basal energy production rate and substrate use in stable cirrhotic patients.
        Hepatology. 1990; 12: 106-112
        • Muller M.J.
        • Fenk A.
        • Lautz H.U.
        • Selberg O.
        • Canzler H.
        • Balks H.J.
        • et al.
        Energy expenditure and substrate metabolism in ethanol-induced liver cirrhosis.
        Am J Physiol Endocrinol Metabol. 1991; 260: E338-E344
        • Riggio O.
        • Merli M.
        • Romiti A.
        • Pinto G.
        • Fanella R.
        • Attili A.F.
        • et al.
        Early postprandial energy expenditure and macronutrient use after a mixed meal in cirrhotic patients.
        J Parenter Enteral Nutr. 1992; 16: 445-450
        • Druml W.
        • Fischer M.
        • Pidlich J.
        • Lenz K.
        Fat elimination in chronic hepatic failure: long-chain vs medium-chain triglycerides.
        Am J Clin Nutr. 1995; 61: 812-817
        • Müller M.
        • Rieger A.
        • Willmann O.
        • Lautz H.
        • Balks H.
        • Von Zur Mühlen A.
        • et al.
        Metabolic responses to lipid infusions in patients with liver cirrhosis.
        Clin Nutr. 1992; 11: 193-206
        • Cabre E.
        • Abad-Lacruz A.
        • Nunez M.
        • González-Huix F.
        • Fernandez-Banares F.
        • Gil A.
        • et al.
        The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis.
        Am J Gastroenterol. 1993; 88
        • Cabre E.
        • Nunez M.
        • Gonzalez-Huin F.
        • Fernandez-Banares F.
        • Abad A.
        • Gil A.
        • et al.
        Clinical and nutritional factors predictive of plasma lipid unsaturation deficiency in advanced liver cirrhosis: a logistic regression analysis.
        Am J Gastroenterol. 1993; 88
        • Croci I.
        • Byrne N.M.
        • Choquette S.
        • Hills A.P.
        • Chachay V.S.
        • Clouston A.D.
        • et al.
        Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
        Gut. 2012; (gutjnl-2012-302789)
        • McCullough A.J.
        • Tavill A.S.
        Disordered energy and protein metabolism in liver disease.
        McCullough Semin Liv Dis. 1991; 11: 265-277
        • Hirsch S.
        • de la Maza M.P.
        • Gattás V.
        • Barrera G.
        • Petermann M.
        • Gotteland M.
        • et al.
        Nutritional support in alcoholic cirrhotic patients improves host defenses.
        J Am Coll Nutr. 1999; 18: 434-441
        • Ballmer P.E.
        • Reichen J.
        • McNurlan M.A.
        • Sterchi A.
        • Anderson S.E.
        • Garlick P.J.
        Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver.
        Hepatology. 1996; 24: 53-59
        • Ballmer P.E.
        • Walshe D.
        • McNurlan M.A.
        • Watson H.
        • Brunt P.W.
        • Garlic P.J.
        Albumin synthesis rates in cirrhosis: correlation with child-turcotte classification.
        Hepatology. 1993; 18: 292-297
        • Nielsen K.
        • Kondrup J.
        • Martinsen L.
        • Døssing H.
        • Larsson B.
        • Stilling B.
        • et al.
        Long-term oral refeeding of patients with cirrhosis of the liver.
        Br J Nutr. 1995; 74: 557-567
        • Schütz T.
        • Bechstein W.-O.
        • Neuhaus P.
        • Lochs H.
        • Plauth M.
        Clinical practice of nutrition in acute liver failure—a European survey.
        Clin Nutr. 2004; 23: 975-982
        • Schneeweiss B.
        • Pammer J.
        • Ratheiser K.
        • Schneider B.
        • Madl C.
        • Kramer L.
        • et al.
        Energy metabolism in acute hepatic failure.
        Gastroenterology. 1993; 105: 1515-1521
        • Walsh T.S.
        • Wigmore S.J.
        • Hopton P.
        • Richardson R.
        • Lee A.
        Energy expenditure in acetaminophen-induced fulminant hepatic failure.
        Crit Care Med. 2000; 28: 649-654
        • Campillo B.
        • Bories P.
        • Pornin B.
        • Devanlay M.
        • Linsker S.
        • Guillemin A.
        • et al.
        Energy expenditure and the use of nutriments in cirrhotic patients fasting and at rest. Influence of alcoholic hepatitis and the severity score of the disease.
        Gastroenterol Clin Biol. 1989; 13: 544-550
        • John W.J.
        • Phillips R.
        • Ott L.
        • Adams L.J.
        • Mcclain C.J.
        Resting energy expenditure in patients with alcoholic hepatitis.
        J Parenter Enteral Nutr. 1989; 13: 124-127
        • Pierrugues R.
        • Blanc P.
        • Daures J.
        • Michel H.
        Relationship of resting energy expenditure with liver function and nutritional status in patients with alcoholic cirrhosis.
        Nutrition (Burbank, Los Angeles County, Calif). 1992; 8: 22-25
        • Jhangiani S.S.
        • Agarwal N.
        • Holmes R.
        • Cayten C.
        • Pitchumoni C.
        Energy expenditure in chronic alcoholics with and without liver disease.
        Am J Clin Nutr. 1986; 44: 323-329
        • Levine J.A.
        • Harris M.M.
        • Morgan M.Y.
        Energy expenditure in chronic alcohol abuse.
        Eur J Clin Invest. 2000; 30: 779-786
        • Addolorato G.
        • Capristo E.
        • Caputo F.
        • Greco A.V.
        • Ceccanti M.
        • Stefanini G.F.
        • et al.
        Nutritional status and body fluid distribution in chronic alcoholics compared with controls.
        Alcohol Clin Exp Res. 1999; 23: 1232-1237
        • Tarantino G.
        • Marra M.
        • Contaldo F.
        • Pasanisi F.
        Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease.
        Clin Invest Med. 2008; 31: 24-29
        • Kotronen A.
        • Seppälä-Lindroos A.
        • Vehkavaara S.
        • Bergholm R.
        • Frayn K.N.
        • Fielding B.A.
        • et al.
        Liver fat and lipid oxidation in humans.
        Liver Int. 2009; 29: 1439-1446
        • Perseghin G.
        • Mazzaferro V.
        • Benedini S.
        • Pulvirenti A.
        • Coppa J.
        • Regalia E.
        • et al.
        Resting energy expenditure in diabetic and nondiabetic patients with liver cirrhosis: relation with insulin sensitivity and effect of liver transplantation and immunosuppressive therapy.
        Am J Clin Nutr. 2002; 76: 541-548
        • Shanbhogue R.L.
        • Bistrian B.R.
        • Jenkins R.L.
        • Jones C.
        • Benotti P.
        • Blackburn G.L.
        Resting energy expenditure in patients with end-stage liver disease and in normal population.
        J Parenter Enteral Nutr. 1987; 11: 305-308
        • Madden A.M.
        • Morgan M.Y.
        Resting energy expenditure should be measured in patients with cirrhosis, not predicted.
        Hepatology. 1999; 30: 655-664
        • Mathur S.
        • Peng S.
        • Gane E.J.
        • McCall J.L.
        • Plank L.D.
        Hypermetabolism predicts reduced transplant-free survival independent of MELD and Child-Pugh scores in liver cirrhosis.
        Nutrition. 2007; 23: 398-403
        • Müller M.J.
        • Böttcher J.
        • Selberg O.
        • Weselmann S.
        • Böker K.H.
        • Schwarze M.
        • et al.
        Hypermetabolism in clinically stable patients with liver cirrhosis–.
        Am J Clin Nutr. 1999; 69: 1194-1201
        • Plauth M.
        • Schütz T.
        • Buckendahl D.P.
        • Kreymann G.
        • Pirlich M.
        • Grüngreiff S.
        • et al.
        Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism.
        J Hepatol. 2004; 40: 228-233
        • Hipskind P.
        • Glass C.
        • Charlton D.
        • Nowak D.
        • Dasarathy S.
        Do handheld calorimeters have a role in assessment of nutrition needs in hospitalized patients? A systematic review of literature.
        Nutr Clin Pract. 2011; 26: 426-433
        • Glass C.
        • Hipskind P.
        • Cole D.
        • Lopez R.
        • Dasarathy S.
        Handheld calorimeter is a valid instrument to quantify resting energy expenditure in hospitalized cirrhotic patients: a prospective study.
        Nutr Clin Pract. 2012; 27: 677-688
        • Nielsen K.
        • Kondrup J.
        • Martinsen L.
        • Stilling B.
        • Wikman B.
        Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis.
        Br J Nutr. 1993; 69: 665-679
        • Campillo B.
        • Bories P.N.
        • Devanlay M.
        • Sommer F.
        • Wirquin E.
        • Fouet P.
        The thermogenic and metabolic effects of food in liver cirrhosis: consequences on the storage of nutrients and the hormonal counterregulatory response.
        Metabolism. 1992; 41: 476-482
        • DeLissio M.
        • Goodyear L.J.
        • Fuller S.
        • Krawitt E.L.
        • Devlin J.T.
        Effects of treadmill exercise on fuel metabolism in hepatic cirrhosis.
        J Appl Physiol (Bethesda, Md: 1985). 1991; 70: 210-215
        • Muller M.J.
        • Dettmer A.
        • Tettenborn M.
        • Radoch E.
        • Fichter J.
        • Wagner T.O.
        • et al.
        Metabolic, endocrine, haemodynamic and pulmonary responses to different types of exercise in individuals with normal or reduced liver function.
        Eur J Appl Physiol Occup Physiol. 1996; 74: 246-257
        • Kondrup J.
        • Muller M.J.
        Energy and protein requirements of patients with chronic liver disease.
        J Hepatol. 1997; 27: 239-247
        • Dolz C.
        • Raurich J.M.
        • Ibanez J.
        • Obrador A.
        • Marse P.
        • Gaya J.
        Ascites increases the resting energy expenditure in liver cirrhosis.
        Gastroenterology. 1991; 100: 738-744
        • Weimann A.
        • Braga M.
        • Carli F.
        • Higashiguchi T.
        • Hubner M.
        • Klek S.
        • et al.
        ESPEN guideline: clinical nutrition in surgery.
        Clin Nutr. 2017; 36: 623-650
        • Plevak D.J.
        • DiCecco S.R.
        • Wiesner R.H.
        • Porayko M.K.
        • Wahlstrom H.E.
        • Janzow D.J.
        • et al.
        Nutritional support for liver transplantation: identifying caloric and protein requirements.
        Mayo Clin Proc. 1994; 69: 225-230
        • Weimann A.
        • Kuse E.R.
        • Bechstein W.O.
        • Neuberger J.M.
        • Plauth M.
        • Pichlmayr R.
        Perioperative parenteral and enteral nutrition for patients undergoing orthotopic liver transplantation. Results of a questionnaire from 16 European transplant units.
        Transpl Int. 1998; 11: S289-S291
        • Plank L.D.
        • Metzger D.J.
        • McCall J.L.
        • Barclay K.L.
        • Gane E.J.
        • Streat S.J.
        • et al.
        Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgery.
        Ann Surg. 2001; 234: 245-255
        • Hussaini S.H.
        • Oldroyd B.
        • Stewart S.P.
        • Soo S.
        • Roman F.
        • Smith M.A.
        • et al.
        Effects of orthotopic liver transplantation on body composition.
        Liver. 1998; 18: 173-179
        • Tietge U.J.
        • Selberg O.
        • Kreter A.
        • Bahr M.J.
        • Pirlich M.
        • Burchert W.
        • et al.
        Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
        Liver Transplant. 2004; 10: 1030-1040
        • Laryea M.
        • Watt K.D.
        • Molinari M.
        • Walsh M.J.
        • McAlister V.C.
        • Marotta P.J.
        • et al.
        Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.
        Liver Transplant. 2007; 13: 1109-1114
        • Merli M.
        • Giusto M.
        • Riggio O.
        • Gentili F.
        • Molinaro A.
        • Attili A.F.
        • et al.
        Improvement of nutritional status in malnourished cirrhotic patients one year after liver transplantation.
        E Spen Eur E J Clin Nutr Metabol. 2011; 6: e142-e147
        • Schutz T.
        • Hudjetz H.
        • Roske A.E.
        • Katzorke C.
        • Kreymann G.
        • Budde K.
        • et al.
        Weight gain in long-term survivors of kidney or liver transplantation--another paradigm of sarcopenic obesity?.
        Nutrition. 2012; 28: 378-383
        • Krasnoff J.B.
        • Vintro A.Q.
        • Ascher N.L.
        • Bass N.M.
        • Dodd M.J.
        • Painter P.L.
        Objective measures of health-related quality of life over 24 months post-liver transplantation.
        Clin Transplant. 2005; 19: 1-9
        • Wiesinger G.F.
        • Quittan M.
        • Zimmermann K.
        • Nuhr M.
        • Wichlas M.
        • Bodingbauer M.
        • et al.
        Physical performance and health-related quality of life in men on a liver transplantation waiting list.
        J Rehabil Med. 2001; 33: 260-265
        • Dunn M.A.
        • Josbeno D.A.
        • Schmotzer A.R.
        • Tevar A.D.
        • DiMartini A.F.
        • Landsittel D.P.
        • et al.
        The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates.
        Liver Transplant. 2016; 22: 1324-1332
        • Roman E.
        • Torrades M.T.
        • Nadal M.J.
        • Cardenas G.
        • Nieto J.C.
        • Vidal S.
        • et al.
        Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis.
        Dig Dis Sci. 2014; 59: 1966-1975
        • Pieber K.
        • Crevenna R.
        • Nuhr M.J.
        • Quittan M.
        • Peck-Radosavljevic M.
        • Fialka-Moser V.
        • et al.
        Aerobic capacity, muscle strength and health-related quality of life before and after orthotopic liver transplantation: preliminary data of an Austrian transplantation centre.
        J Rehabil Med. 2006; 38: 322-328
        • Williams T.J.
        • McKenna M.J.
        Exercise limitation following transplantation.
        Compr Physiol. 2012; 2: 1937-1979
        • Krasnoff J.B.
        • Vintro A.Q.
        • Ascher N.L.
        • Bass N.M.
        • Paul S.M.
        • Dodd M.J.
        • et al.
        A randomized trial of exercise and dietary counseling after liver transplantation.
        Am J Transplant. 2006; 6: 1896-1905
        • Rutherford A.
        • Davern T.
        • Hay J.E.
        • Murray N.G.
        • Hassanein T.
        • Lee W.M.
        • et al.
        Influence of high body mass index on outcome in acute liver failure.
        Clin Gastroenterol Hepatol. 2006; 4: 1544-1549
        • Canbay A.
        • Chen S.Y.
        • Gieseler R.K.
        • Malago M.
        • Karliova M.
        • Gerken G.
        • et al.
        Overweight patients are more susceptible for acute liver failure.
        Hepatogastroenterology. 2005; 52: 1516-1520
        • De Caprio C.
        • Alfano A.
        • Senatore I.
        • Zarrella L.
        • Pasanisi F.
        • Contaldo F.
        Severe acute liver damage in anorexia nervosa: two case reports.
        Nutrition. 2006; 22: 572-575
        • Rautou P.E.
        • Cazals-Hatem D.
        • Moreau R.
        • Francoz C.
        • Feldmann G.
        • Lebrec D.
        • et al.
        Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy.
        Gastroenterology. 2008; 135 (8.e1-3): 840-848
        • Mendenhall C.L.
        • Moritz T.E.
        • Roselle G.A.
        • Morgan T.R.
        • Nemchausky B.A.
        • Tamburro C.H.
        • et al.
        A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a department of Veterans affairs cooperative study.
        Hepatology. 1993; 17: 564-576
        • Mendenhall C.L.
        • Moritz T.E.
        • Roselle G.A.
        • Morgan T.R.
        • Nemchausky B.A.
        • Tamburro C.H.
        • et al.
        Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA cooperative study group #275.
        J Parenter Enteral Nutr. 1995; 19: 258-265
        • Mendenhall C.L.
        • Tosch T.
        • Weesner R.E.
        • Garcia-Pont P.
        • Goldberg S.J.
        • Kiernan T.
        • et al.
        VA cooperative study on alcoholic hepatitis. II: prognostic significance of protein-calorie malnutrition.
        Am J Clin Nutr. 1986; 43: 213-218
        • Moreno C.
        • Deltenre P.
        • Senterre C.
        • Louvet A.
        • Gustot T.
        • Bastens B.
        • et al.
        Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids.
        Gastroenterology. 2016; 150 (e8): 903-910
        • Caregaro L.
        • Alberino F.
        • Amodio P.
        • Merkel C.
        • Bolognesi M.
        • Angeli P.
        • et al.
        Malnutrition in alcoholic and virus-related cirrhosis.
        Am J Clin Nutr. 1996; 63: 602-609
        • Merli M.
        • Riggio O.
        • Dally L.
        Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi).
        Hepatology. 1996; 23: 1041-1046
        • Merli M.
        • Giusto M.
        • Gentili F.
        • Novelli G.
        • Ferretti G.
        • Riggio O.
        • et al.
        Nutritional status: its influence on the outcome of patients undergoing liver transplantation.
        Liver Int Off J Int Assoc Stud Liver. 2010; 30: 208-214
        • Merli M.
        • Giusto M.
        • Lucidi C.
        • Giannelli V.
        • Pentassuglio I.
        • Di Gregorio V.
        • et al.
        Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study.
        Metab Brain Dis. 2013; 28: 281-284
        • Soros P.
        • Bottcher J.
        • Weissenborn K.
        • Selberg O.
        • Muller M.J.
        Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study.
        J Gastroenterol Hepatol. 2008; 23: 606-610
      4. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
        J Hepatol. 2016; 64: 1388-1402
        • Chalasani N.
        • Younossi Z.
        • Lavine J.E.
        • Diehl A.M.
        • Brunt E.M.
        • Cusi K.
        • et al.
        The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American gastroenterological association, American association for the study of liver diseases, and American college of gastroenterology.
        Gastroenterology. 2012; 142: 1592-1609
        • Caldwell S.
        • Argo C.
        The natural history of non-alcoholic fatty liver disease.
        Dig Dis. 2010; 28: 162-168
        • Musso G.
        • Gambino R.
        • Cassader M.
        • Pagano G.
        Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.
        Ann Med. 2011; 43: 617-649
        • Targher G.
        • Day C.P.
        Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease.
        Hepatology. 2011; 53: 375
        • Haflidadottir S.
        • Jonasson J.G.
        • Norland H.
        • Einarsdottir S.O.
        • Kleiner D.E.
        • Lund S.H.
        • et al.
        Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.
        BMC Gastroenterol. 2014; 14: 166
        • Dick A.A.
        • Spitzer A.L.
        • Seifert C.F.
        • Deckert A.
        • Carithers Jr., R.L.
        • Reyes J.D.
        • et al.
        Liver transplantation at the extremes of the body mass index.
        Liver Transplant. 2009; 15: 968-977
        • Nair S.
        • Verma S.
        • Thuluvath P.J.
        Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.
        Hepatology. 2002; 35: 105-109
        • Loomba R.
        • Abraham M.
        • Unalp A.
        • Wilson L.
        • Lavine J.
        • Doo E.
        • et al.
        Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.
        Hepatology. 2012; 56: 943-951
        • Vernon G.
        • Baranova A.
        • Younossi Z.M.
        Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
        Aliment Pharmacol Ther. 2011; 34: 274-285
        • Fracanzani A.L.
        • Valenti L.
        • Bugianesi E.
        • Andreoletti M.
        • Colli A.
        • Vanni E.
        • et al.
        Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
        Hepatology. 2008; 48: 792-798
        • Armstrong M.J.
        • Adams L.A.
        • Canbay A.
        • Syn W.K.
        Extrahepatic complications of nonalcoholic fatty liver disease.
        Hepatology. 2014; 59: 1174-1197
        • Kondrup J.
        • Rasmussen H.H.
        • Hamberg O.
        • Stanga Z.
        Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials.
        Clin Nutr. 2003; 22: 321-336
        • Sorensen J.
        • Kondrup J.
        • Prokopowicz J.
        • Schiesser M.
        • Krahenbuhl L.
        • Meier R.
        • et al.
        EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome.
        Clin Nutr. 2008; 27: 340-349
        • Kondrup J.
        • Allison S.P.
        • Elia M.
        • Vellas B.
        • Plauth M.
        ESPEN guidelines for nutrition screening 2002.
        Clin Nutr. 2003; 22: 415-421
        • Amodio P.
        • Bemeur C.
        • Butterworth R.
        • Cordoba J.
        • Kato A.
        • Montagnese S.
        • et al.
        The nutritional management of hepatic encephalopathy in patients with cirrhosis: international society for hepatic encephalopathy and nitrogen metabolism consensus.
        Hepatology. 2013; 58: 325-336
        • Arora S.
        • Mattina C.
        • McAnenny C.
        • O'Sullivan N.
        • McGeeney L.
        • Calder N.
        • et al.
        The developement and validation of a nutritional prioritising tool for use in patients with chronic liver disease.
        J Hepatol. 2012; 56: S241
        • Borhofen S.M.
        • Gerner C.
        • Lehmann J.
        • Fimmers R.
        • Gortzen J.
        • Hey B.
        • et al.
        The royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis.
        Dig Dis Sci. 2016; 61: 1735-1743
        • Schutte K.
        • Tippelt B.
        • Schulz C.
        • Rohl F.W.
        • Feneberg A.
        • Seidensticker R.
        • et al.
        Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC).
        Clin Nutr. 2015; 34: 1122-1127
        • Tandon P.
        • Raman M.
        • Mourtzakis M.
        • Merli M.
        A practical approach to nutritional screening and assessment in cirrhosis.
        Hepatology. 2017; 65: 1044-1057
        • Figueiredo F.A.
        • Perez R.M.
        • Freitas M.M.
        • Kondo M.
        Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis.
        J Gastroenterol. 2006; 41: 476-482
        • Morgan M.Y.
        • Madden A.M.
        • Jennings G.
        • Elia M.
        • Fuller N.J.
        Two-component models are of limited value for the assessment of body composition in patients with cirrhosis.
        Am J Clin Nutr. 2006; 84: 1151-1162
        • Pirlich M.
        • Schutz T.
        • Spachos T.
        • Ertl S.
        • Weiss M.L.
        • Lochs H.
        • et al.
        Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites.
        Hepatology. 2000; 32: 1208-1215
        • Mendenhall C.
        • Roselle G.A.
        • Gartside P.
        • Moritz T.
        Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two veterans administration cooperative studies.
        Alcohol Clin Exp Res. 1995; 19: 635-641
        • Peres W.A.
        • Lento D.F.
        • Baluz K.
        • Ramalho A.
        Phase angle as a nutritional evaluation tool in all stages of chronic liver disease.
        Nutr Hosp. 2012; 27: 2072-2078
        • Morgan M.Y.
        • Madden A.M.
        • Soulsby C.T.
        • Morris R.W.
        Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis.
        Hepatology. 2006; 44: 823-835
        • Gunsar F.
        • Raimondo M.L.
        • Jones S.
        • Terreni N.
        • Wong C.
        • Patch D.
        • et al.
        Nutritional status and prognosis in cirrhotic patients.
        Aliment Pharmacol Ther. 2006; 24: 563-572
        • Figueiredo F.A.
        • Dickson E.R.
        • Pasha T.M.
        • Porayko M.K.
        • Therneau T.M.
        • Malinchoc M.
        • et al.
        Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease.
        Liver Transplant. 2000; 6: 575-581
        • Huisman E.J.
        • Trip E.J.
        • Siersema P.D.
        • van Hoek B.
        • van Erpecum K.J.
        Protein energy malnutrition predicts complications in liver cirrhosis.
        Eur J Gastroenterol Hepatol. 2011; 23: 982-989
        • Alvares-da-Silva M.R.
        • Reverbel da Silveira T.
        Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.
        Nutrition. 2005; 21: 113-117
        • Stanca C.M.
        • Bach N.
        • Krause C.
        • Tandon N.
        • Freni M.A.
        • Gutierrez J.A.
        • et al.
        Evaluation of fatigue in U.S. patients with primary biliary cirrhosis.
        Am J Gastroenterol. 2005; 100: 1104-1109
        • Norman K.
        • Kirchner H.
        • Freudenreich M.
        • Ockenga J.
        • Lochs H.
        • Pirlich M.
        Three month intervention with protein and energy rich supplements improve muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease--a randomized controlled trial.
        Clin Nutr. 2008; 27: 48-56
        • Fernandes S.A.
        • Bassani L.
        • Nunes F.F.
        • Aydos M.E.
        • Alves A.V.
        • Marroni C.A.
        Nutritional assessment in patients with cirrhosis.
        Arq Gastroenterol. 2012; 49: 19-27
        • Norman K.
        • Stobaus N.
        • Pirlich M.
        • Bosy-Westphal A.
        Bioelectrical phase angle and impedance vector analysis--clinical relevance and applicability of impedance parameters.
        Clin Nutr. 2012; 31: 854-861
        • Belarmino G.
        • Gonzalez M.C.
        • Torrinhas R.S.
        • Sala P.
        • Andraus W.
        • D'Albuquerque L.A.
        • et al.
        Phase angle obtained by bioelectrical impedance analysis independently predicts mortality in patients with cirrhosis.
        World J Hepatol. 2017; 9: 401-408
        • Ruiz-Margain A.
        • Macias-Rodriguez R.U.
        • Duarte-Rojo A.
        • Rios-Torres S.L.
        • Espinosa-Cuevas A.
        • Torre A.
        Malnutrition assessed through phase angle and its relation to prognosis in patients with compensated liver cirrhosis: a prospective cohort study.
        Dig Liver Dis. 2015; 47: 309-314
        • Muscaritoli M.
        • Anker S.D.
        • Argiles J.
        • Aversa Z.
        • Bauer J.M.
        • Biolo G.
        • et al.
        Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".
        Clin Nutr. 2010; 29: 154-159
        • Montano-Loza A.J.
        • Meza-Junco J.
        • Prado C.M.
        • Lieffers J.R.
        • Baracos V.E.
        • Bain V.G.
        • et al.
        Muscle wasting is associated with mortality in patients with cirrhosis.
        Clin Gastroenterol Hepatol. 2012; 10 (73.e1): 166-173
        • Tsien C.
        • Shah S.N.
        • McCullough A.J.
        • Dasarathy S.
        Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.
        Eur J Gastroenterol Hepatol. 2013; 25: 85-93
        • Prado C.M.
        • Birdsell L.A.
        • Baracos V.E.
        The emerging role of computerized tomography in assessing cancer cachexia.
        Curr Opin Support Palliat Care. 2009; 3: 269-275
        • Carey E.J.
        • Lai J.C.
        • Wang C.W.
        • Dasarathy S.
        • Lobach I.
        • Montano-Loza A.J.
        • et al.
        A multicenter study to define sarcopenia in patients with end-stage liver disease.
        Liver Transplant. 2017; 23: 625-633
        • Hanai T.
        • Shiraki M.
        • Nishimura K.
        • Imai K.
        • Suetsugu A.
        • Takai K.
        • et al.
        Free fatty acid as a marker of energy malnutrition in liver cirrhosis.
        Hepatol Res. 2014; 44: 218-228
        • Montano-Loza A.J.
        • Angulo P.
        • Meza-Junco J.
        • Prado C.M.
        • Sawyer M.B.
        • Beaumont C.
        • et al.
        Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
        J Cachexia Sarcopenia Muscle. 2016; 7: 126-135
        • Durand F.
        • Buyse S.
        • Francoz C.
        • Laouenan C.
        • Bruno O.
        • Belghiti J.
        • et al.
        Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography.
        J Hepatol. 2014; 60: 1151-1157
        • Dasarathy S.
        Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation.
        Dig Dis Sci. 2013; 58: 3103-3111
        • Tsien C.
        • Garber A.
        • Narayanan A.
        • Shah S.N.
        • Barnes D.
        • Eghtesad B.
        • et al.
        Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation.
        J Gastroenterol Hepatol. 2014; 29: 1250-1257
        • Issa D.
        • Alkhouri N.
        • Tsien C.
        • Shah S.
        • Lopez R.
        • McCullough A.
        • et al.
        Presence of sarcopenia (muscle wasting) in patients with nonalcoholic steatohepatitis.
        Hepatology. 2014; 60: 428-429
        • Rutten I.J.G.
        • Ubachs J.
        • Kruitwagen R.
        • Beets-Tan R.G.H.
        • Olde Damink S.W.M.
        • Van Gorp T.
        Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer.
        J Cachexia Sarcopenia Muscle. 2017; 8: 630-638
        • Baracos V.E.
        Psoas as a sentinel muscle for sarcopenia: a flawed premise.
        J Cachexia Sarcopenia Muscle. 2017; 8: 527-528
        • Tandon P.
        • Low G.
        • Mourtzakis M.
        • Zenith L.
        • Myers R.P.
        • Abraldes J.G.
        • et al.
        A model to identify sarcopenia in patients with cirrhosis.
        Clin Gastroenterol Hepatol. 2016; 14 (e3): 1473-1480
        • Wang C.W.
        • Feng S.
        • Covinsky K.E.
        • Hayssen H.
        • Zhou L.Q.
        • Yeh B.M.
        • et al.
        A comparison of muscle function, mass, and quality in liver transplant candidates: results from the functional assessment in liver transplantation study.
        Transplantation. 2016; 100: 1692-1698
        • Yadav A.
        • Chang Y.H.
        • Carpenter S.
        • Silva A.C.
        • Rakela J.
        • Aqel B.A.
        • et al.
        Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates.
        Clin Transplant. 2015; 29: 134-141
        • Dunn M.A.
        • Josbeno D.A.
        • Tevar A.D.
        • Rachakonda V.
        • Ganesh S.R.
        • Schmotzer A.R.
        • et al.
        Frailty as tested by gait speed is an independent risk factor for cirrhosis complications that require hospitalization.
        Am J Gastroenterol. 2016; 111: 1768-1775
        • Lai J.C.
        Defining the threshold for too sick for transplant.
        Curr Opin Organ Transplant. 2016; 21: 127-132
        • Sinclair M.
        • Poltavskiy E.
        • Dodge J.L.
        • Lai J.C.
        Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist.
        World J Gastroenterol. 2017; 23: 899-905
        • Painter P.L.
        • Luetkemeier M.J.
        • Moore G.E.
        • Dibble S.L.
        • Green G.A.
        • Myll J.O.
        • et al.
        Health-related fitness and quality of life in organ transplant recipients.
        Transplantation. 1997; 64: 1795-1800
        • Bernal W.
        • Hyyrylainen A.
        • Gera A.
        • Audimoolam V.K.
        • McPhail M.J.
        • Auzinger G.
        • et al.
        Lessons from look-back in acute liver failure? A single centre experience of 3300 patients.
        J Hepatol. 2013; 59: 74-80
        • Rabinowich L.
        • Wendon J.
        • Bernal W.
        • Shibolet O.
        Clinical management of acute liver failure: results of an international multi-center survey.
        World J Gastroenterol. 2016; 22: 7595-7603
        • Clemmesen J.O.
        • Larsen F.S.
        • Kondrup J.
        • Hansen B.A.
        • Ott P.
        Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration.
        Hepatology. 1999; 29: 648-653
        • Tofteng F.
        • Hauerberg J.
        • Hansen B.A.
        • Pedersen C.B.
        • Jørgensen L.
        • Larsen F.S.
        Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure.
        J Cerebr Blood Flow Metabol. 2006; 26: 21-27
        • Reintam Blaser A.
        • Starkopf J.
        • Alhazzani W.
        • Berger M.M.
        • Casaer M.P.
        • Deane A.M.
        • et al.
        Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines.
        Intensive Care Med. 2017; 43: 380-398
        • McClave S.A.
        • Taylor B.E.
        • Martindale R.G.
        • Warren M.M.
        • Johnson D.R.
        • Braunschweig C.
        • et al.
        Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American society for parenteral and enteral nutrition (A.S.P.E.N.).
        J Parenter Enteral Nutr. 2016; 40: 159-211
        • Mendenhall C.
        • Bongiovanni G.
        • Goldberg S.
        • Miller B.
        • Moore J.
        • Rouster S.
        • et al.
        VA cooperative study on alcoholic hepatitis. III: changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy.
        J Parenter Enteral Nutr. 1985; 9: 590-596
        • Bonkovsky H.L.
        • Fiellin D.A.
        • Smith G.S.
        • Slaker D.P.
        • Simon D.
        • Galambos J.T.
        A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function.
        Am J Gastroenterol. 1991; 86: 1200-1208
        • Bonkovsky H.L.
        • Singh R.H.
        • Jafri I.H.
        • Fiellin D.A.
        • Smith G.S.
        • Simon D.
        • et al.
        A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition.
        Am J Gastroenterol. 1991; 86: 1209-1218
        • Cabre E.
        • Rodriguez-Iglesias P.
        • Caballeria J.
        • Quer J.C.
        • Sanchez-Lombrana J.L.
        • Pares A.
        • et al.
        Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial.
        Hepatology. 2000; 32: 36-42
        • Nasrallah S.M.
        • Galambos J.T.
        Aminoacid therapy of alcoholic hepatitis.
        Lancet. 1980; 2: 1276-1277
        • Koretz R.L.
        • Avenell A.
        • Lipman T.O.
        Nutritional support for liver disease.
        Cochrane Database Syst Rev. 2012; Cd008344
        • Antar R.
        • Wong P.
        • Ghali P.
        A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis.
        Can J Gastroenterol. 2012; 26: 463-467
        • Fialla A.D.
        • Israelsen M.
        • Hamberg O.
        • Krag A.
        • Gluud L.L.
        Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis.
        Liver Int Off J Int Assoc Stud Liver. 2015; 35: 2072-2078
        • Koretz R.L.
        The evidence for the use of nutritional support in liver disease.
        Curr Opin Gastroenterol. 2014; 30: 208-214
        • Kearns P.J.
        • Young H.
        • Garcia G.
        • Blaschke T.
        • O'Hanlon G.
        • Rinki M.
        • et al.
        Accelerated improvement of alcoholic liver disease with enteral nutrition.
        Gastroenterology. 1992; 102: 200-205
        • Mezey E.
        • Caballeria J.
        • Mitchell M.C.
        • Pares A.
        • Herlong H.F.
        • Rodes J.
        Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial.
        Hepatology. 1991; 14: 1090-1096
        • Galambos J.T.
        • Hersh T.
        • Fulenwider J.T.
        • Ansley J.D.
        • Rudman D.
        Hyperalimentation in alcoholic hepatitis.
        Am J Gastroenterol. 1979; 72: 535-541
        • Diehl A.M.
        • Boitnott J.K.
        • Herlong H.F.
        • Potter J.J.
        • Van Duyn M.A.
        • Chandler E.
        • et al.
        Effect of parenteral amino acid supplementation in alcoholic hepatitis.
        Hepatology. 1985; 5: 57-63
        • Calvey H.
        • Davis M.
        • Williams R.
        Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis.
        J Hepatol. 1985; 1: 141-151
        • Achord J.L.
        A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis.
        Am J Gastroenterol. 1987; 82: 871-875
        • Simon D.
        • Galambos J.T.
        A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis.
        J Hepatol. 1988; 7: 200-207
        • McClave S.A.
        • DiBaise J.K.
        • Mullin G.E.
        • Martindale R.G.
        ACG clinical guideline: nutrition therapy in the adult hospitalized patient.
        Am J Gastroenterol. 2016; 111 (quiz 35): 315-334
        • Annetta M.G.
        • Pittiruti M.
        • Vecchiarelli P.
        • Silvestri D.
        • Caricato A.
        • Antonelli M.
        Immunonutrients in critically ill patients: an analysis of the most recent literature.
        Minerva Anestesiol. 2016; 82: 320-331
        • Plank L.D.
        • Mathur S.
        • Gane E.J.
        • Peng S.L.
        • Gillanders L.K.
        • McIlroy K.
        • et al.
        Perioperative immunonutrition in patients undergoing liver transplantation: a randomized double-blind trial.
        Hepatology. 2015; 61: 639-647
        • Soberon S.
        • Pauley M.P.
        • Duplantier R.
        • Fan A.
        • Halsted C.H.
        Metabolic effects of enteral formula feeding in alcoholic hepatitis.
        Hepatology. 1987; 7: 1204-1209
        • Smith J.
        • Horowitz J.
        • Henderson J.M.
        • Heymsfield S.
        Enteral hyperalimentation in undernourished patients with cirrhosis and ascites.
        Am J Clin Nutr. 1982; 35: 56-72
        • Majumdar S.K.
        • Shaw G.K.
        • O'Gorman P.
        • Aps E.J.
        • Offerman E.L.
        • Thomson A.D.
        Blood vitamin status (B1, B2, B6, folic acid and B12) in patients with alcoholic liver disease.
        Int J Vitam Nutr Res. 1982; 52: 266-271
        • Ouziel R.
        • Trepo E.
        • Cremer A.
        • Moreno C.
        • Degre D.
        • Chaouni M.
        • et al.
        Correction of all-trans retinoic acid deficiency in alcoholic cirrhosis lessens the excessive inflammatory monocyte response: a translational study.
        Liver Int. 2014; 34: 343-352
        • Anty R.
        • Canivet C.M.
        • Patouraux S.
        • Ferrari-Panaia P.
        • Saint-Paul M.C.
        • Huet P.M.
        • et al.
        Severe Vitamin D deficiency may be an additional cofactor for the occurrence of alcoholic steatohepatitis.
        Alcohol Clin Exp Res. 2015; 39: 1027-1033
        • Flannery A.H.
        • Adkins D.A.
        • Cook A.M.
        Unpeeling the evidence for the banana bag: evidence-based recommendations for the management of alcohol-associated vitamin and electrolyte deficiencies in the ICU.
        Crit Care Med. 2016; 44: 1545-1552
        • Mitchell M.C.
        • Friedman L.S.
        • McClain C.J.
        Medical management of severe alcoholic hepatitis: expert review from the clinical practice updates committee of the AGA institute.
        Clin Gastroenterol Hepatol. 2017; 15: 5-12
        • McClain C.J.
        • Antonow D.R.
        • Cohen D.A.
        • Shedlofsky S.I.
        Zinc metabolism in alcoholic liver disease.
        Alcohol Clin Exp Res. 1986; 10: 582-589
        • Hu J.
        • Juan W.
        • Sahyoun N.R.
        Intake and biomarkers of folate and risk of cancer morbidity in older adults, NHANES 1999-2002 with medicare linkage.
        PLoS One. 2016; 11e0148697
        • Demir R.
        • Acar G.
        • Tanriover G.
        • Seval Y.
        • Kayisli U.A.
        • Agar A.
        Effects of excess vitamin B6 intake on cerebral cortex neurons in rat: an ultrastructural study.
        Folia Histochem Cytobiol. 2005; 43: 143-150
        • Kaur P.
        • Mishra S.K.
        • Mithal A.
        Vitamin D toxicity resulting from overzealous correction of vitamin D deficiency.
        Clin Endocrinol (Oxf). 2015; 83: 327-331
        • Rachakonda V.
        • Gabbert C.
        • Raina A.
        • Bell L.N.
        • Cooper S.
        • Malik S.
        • et al.
        Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways.
        PLoS One. 2014; 9e113860
        • Tsien C.D.
        • McCullough A.J.
        • Dasarathy S.
        Late evening snack: exploiting a period of anabolic opportunity in cirrhosis.
        J Gastroenterol Hepatol. 2012; 27: 430-441
        • Keohane P.P.
        • Attrill H.
        • Grimble G.
        • Spiller R.
        • Frost P.
        • Silk D.B.
        Enteral nutrition in malnourished patients with hepatic cirrhosis and acute encephalopathy.
        J Parenter Enteral Nutr. 1983; 7: 346-350
        • Morgan T.R.
        • Moritz T.E.
        • Mendenhall C.L.
        • Haas R.
        Protein consumption and hepatic encephalopathy in alcoholic hepatitis. VA cooperative study group #275.
        J Am Coll Nutr. 1995; 14: 152-158
        • Thursz M.R.
        • Richardson P.
        • Allison M.
        • Austin A.
        • Bowers M.
        • Day C.P.
        • et al.
        Prednisolone or pentoxifylline for alcoholic hepatitis.
        N Engl J Med. 2015; 372: 1619-1628
        • Verboeket-van de Venne W.P.
        • Westerterp K.R.
        • van Hoek B.
        • Swart G.R.
        Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake.
        Gut. 1995; 36: 110-116
        • Zillikens M.C.
        • van den Berg J.W.
        • Wattimena J.L.
        • Rietveld T.
        • Swart G.R.
        Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls.
        J Hepatol. 1993; 17: 377-383
        • Swart G.R.
        • Zillikens M.C.
        • van Vuure J.K.
        • van den Berg J.W.
        Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver.
        BMJ. 1989; 299: 1202-1203
        • Plank L.D.
        • Gane E.J.
        • Peng S.
        • Muthu C.
        • Mathur S.
        • Gillanders L.
        • et al.
        Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial.
        Hepatology. 2008; 48: 557-566
        • Wang R.T.
        • Koretz R.L.
        • Yee Jr., H.F.
        Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review.
        Am J Med. 2003; 115: 554-559
        • Angulo P.
        • Kleiner D.E.
        • Dam-Larsen S.
        • Adams L.A.
        • Bjornsson E.S.
        • Charatcharoenwitthaya P.
        • et al.
        Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease.
        Gastroenterology. 2015; 149 (e10): 389-397
        • Barker K.B.
        • Palekar N.A.
        • Bowers S.P.
        • Goldberg J.E.
        • Pulcini J.P.
        • Harrison S.A.
        Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.
        Am J Gastroenterol. 2006; 101: 368-373
        • Caiazzo R.
        • Lassailly G.
        • Leteurtre E.
        • Baud G.
        • Verkindt H.
        • Raverdy V.
        • et al.
        Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
        Ann Surg. 2014; 260 (discussion 8-9): 893-898
        • Dixon J.B.
        • Bhathal P.S.
        • O'Brien P.E.
        Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
        Obes Surg. 2006; 16: 1278-1286
        • Harrison S.A.
        • Fecht W.
        • Brunt E.M.
        • Neuschwander-Tetri B.A.
        Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial.
        Hepatology. 2009; 49: 80-86
        • Harrison S.A.
        • Fincke C.
        • Helinski D.
        • Torgerson S.
        • Hayashi P.
        A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients.
        Aliment Pharmacol Ther. 2004; 20: 623-628
        • Lassailly G.
        • Caiazzo R.
        • Buob D.
        • Pigeyre M.
        • Verkindt H.
        • Labreuche J.
        • et al.
        Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients.
        Gastroenterology. 2015; 149 (quiz e15-6): 379-388
        • Stratopoulos C.
        • Papakonstantinou A.
        • Terzis I.
        • Spiliadi C.
        • Dimitriades G.
        • Komesidou V.
        • et al.
        Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity.
        Obes Surg. 2005; 15: 1154-1160
        • Tendler D.
        • Lin S.
        • Yancy Jr., W.S.
        • Mavropoulos J.
        • Sylvestre P.
        • Rockey D.C.
        • et al.
        The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.
        Dig Dis Sci. 2007; 52: 589-593
        • Vilar-Gomez E.
        • Martinez-Perez Y.
        • Calzadilla-Bertot L.
        • Torres-Gonzalez A.
        • Gra-Oramas B.
        • Gonzalez-Fabian L.
        • et al.
        Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis.
        Gastroenterology. 2015; 149 (e5; quiz e14-5): 367-378
        • Haufe S.
        • Engeli S.
        • Kast P.
        • Bohnke J.
        • Utz W.
        • Haas V.
        • et al.
        Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects.
        Hepatology. 2011; 53: 1504-1514
        • Huang M.A.
        • Greenson J.K.
        • Chao C.
        • Anderson L.
        • Peterman D.
        • Jacobson J.
        • et al.
        One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
        Am J Gastroenterol. 2005; 100: 1072-1081
        • Promrat K.
        • Kleiner D.E.
        • Niemeier H.M.
        • Jackvony E.
        • Kearns M.
        • Wands J.R.
        • et al.
        Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.
        Hepatology. 2010; 51: 121-129
        • Zelber-Sagi S.
        • Kessler A.
        • Brazowsky E.
        • Webb M.
        • Lurie Y.
        • Santo M.
        • et al.
        A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
        Clin Gastroenterol Hepatol. 2006; 4: 639-644
        • Mummadi R.R.
        • Kasturi K.S.
        • Chennareddygari S.
        • Sood G.K.
        Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis.
        Clin Gastroenterol Hepatol. 2008; 6: 1396-1402
        • Sasaki A.
        • Nitta H.
        • Otsuka K.
        • Umemura A.
        • Baba S.
        • Obuchi T.
        • et al.
        Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments.
        Front Endocrinol (Lausanne). 2014; 5: 164
        • de Jonge C.
        • Rensen S.S.
        • Koek G.H.
        • Joosten M.F.
        • Buurman W.A.
        • Bouvy N.D.
        • et al.
        Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease.
        Clin Gastroenterol Hepatol. 2013; 11: 1517-1520
        • Schafer S.
        • Kantartzis K.
        • Machann J.
        • Venter C.
        • Niess A.
        • Schick F.
        • et al.
        Lifestyle intervention in individuals with normal versus impaired glucose tolerance.
        Eur J Clin Invest. 2007; 37: 535-543
        • Thomas E.L.
        • Brynes A.E.
        • Hamilton G.
        • Patel N.
        • Spong A.
        • Goldin R.D.
        • et al.
        Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease.
        World J Gastroenterol. 2006; 12: 5813-5819
        • Hickman I.J.
        • Jonsson J.R.
        • Prins J.B.
        • Ash S.
        • Purdie D.M.
        • Clouston A.D.
        • et al.
        Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.
        Gut. 2004; 53: 413-419
        • Nobili V.
        • Manco M.
        • Devito R.
        • Di Ciommo V.
        • Comparcola D.
        • Sartorelli M.R.
        • et al.
        Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
        Hepatology. 2008; 48: 119-128
        • Larson-Meyer D.E.
        • Newcomer B.R.
        • Heilbronn L.K.
        • Volaufova J.
        • Smith S.R.
        • Alfonso A.J.
        • et al.
        Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.
        Obesity (Silver Spring). 2008; 16: 1355-1362
        • Houghton D.
        • Thoma C.
        • Hallsworth K.
        • Cassidy S.
        • Hardy T.
        • Burt A.D.
        • et al.
        Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial.
        Clin Gastroenterol Hepatol. 2017; 15 (e3): 96-102
        • Johnson N.A.
        • Sachinwalla T.
        • Walton D.W.
        • Smith K.
        • Armstrong A.
        • Thompson M.W.
        • et al.
        Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.
        Hepatology. 2009; 50: 1105-1112
        • Sullivan S.
        • Kirk E.P.
        • Mittendorfer B.
        • Patterson B.W.
        • Klein S.
        Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.
        Hepatology. 2012; 55: 1738-1745
        • Lazo M.
        • Solga S.F.
        • Horska A.
        • Bonekamp S.
        • Diehl A.M.
        • Brancati F.L.
        • et al.
        Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.
        Diabetes Care. 2010; 33: 2156-2163
        • Gerber L.
        • Otgonsuren M.
        • Mishra A.
        • Escheik C.
        • Birerdinc A.
        • Stepanova M.
        • et al.
        Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study.
        Aliment Pharmacol Ther. 2012; 36: 772-781
        • Stewart K.E.
        • Haller D.L.
        • Sargeant C.
        • Levenson J.L.
        • Puri P.
        • Sanyal A.J.
        Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models.
        Liver Int Off J Int Assoc Stud Liver. 2015; 35: 936-943
        • Zelber-Sagi S.
        • Buch A.
        • Yeshua H.
        • Vaisman N.
        • Webb M.
        • Harari G.
        • et al.
        Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial.
        World J Gastroenterol. 2014; 20: 4382-4392
        • Centre for Public Health Excellence at NICE (UK)
        • National Collaborating Centre for Primary Care (UK)
        Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children.
        National Institute for Health and Clinical Excellence: Guidance, London2006
        • Lau D.C.
        Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children.
        Can Med Assoc J. 2007; 176: 1103-1106
        • Lau D.C.
        • Douketis J.D.
        • Morrison K.M.
        • Hramiak I.M.
        • Sharma A.M.
        • Ur E.
        2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary].
        CMAJ. 2007; 176: S1-S13
        • Poole R.
        • Kennedy O.J.
        • Roderick P.
        • Fallowfield J.A.
        • Hayes P.C.
        • Parkes J.
        Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes.
        BMJ. 2017; 359: j5024
        • Lin W.Y.
        • Wu C.H.
        • Chu N.F.
        • Chang C.J.
        Efficacy and safety of very-low-calorie diet in Taiwanese: a multicenter randomized, controlled trial.
        Nutrition. 2009; 25: 1129-1136
        • Elias M.C.
        • Parise E.R.
        • de Carvalho L.
        • Szejnfeld D.
        • Netto J.P.
        Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease.
        Nutrition. 2010; 26: 1094-1099
        • Browning J.D.
        • Baker J.A.
        • Rogers T.
        • Davis J.
        • Satapati S.
        • Burgess S.C.
        Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction.
        Am J Clin Nutr. 2011; 93: 1048-1052
        • Ryan M.C.
        • Abbasi F.
        • Lamendola C.
        • Carter S.
        • McLaughlin T.L.
        Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults.
        Diabetes Care. 2007; 30: 1075-1080
        • Kirk E.
        • Reeds D.N.
        • Finck B.N.
        • Mayurranjan M.S.
        • Patterson B.W.
        • Klein S.
        Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.
        Gastroenterology. 2009; 136: 1552-1560
        • Aller R.
        • de Luis D.A.
        • Izaola O.
        • de la Fuente B.
        • Bachiller R.
        Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease.
        Eur Rev Med Pharmacol Sci. 2014; 18: 1041-1047
        • Utzschneider K.M.
        • Bayer-Carter J.L.
        • Arbuckle M.D.
        • Tidwell J.M.
        • Richards T.L.
        • Craft S.
        Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects.
        Br J Nutr. 2013; 109: 1096-1104
        • Markova M.
        • Pivovarova O.
        • Hornemann S.
        • Sucher S.
        • Frahnow T.
        • Wegner K.
        • et al.
        Isocaloric diets high in animal or plant protein reduce liver fat and inflammation in individuals with type 2 diabetes.
        Gastroenterology. 2017; 152 (e8): 571-585
        • Bray G.A.
        Medical consequences of obesity.
        J Clin Endocrinol Metabol. 2004; 89: 2583-2589
        • Stanhope K.L.
        • Schwarz J.M.
        • Keim N.L.
        • Griffen S.C.
        • Bremer A.A.
        • Graham J.L.
        • et al.
        Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.
        J Clin Invest. 2009; 119: 1322-1334
        • Ouyang X.
        • Cirillo P.
        • Sautin Y.
        • McCall S.
        • Bruchette J.L.
        • Diehl A.M.
        • et al.
        Fructose consumption as a risk factor for non-alcoholic fatty liver disease.
        J Hepatol. 2008; 48: 993-999
        • Volynets V.
        • Machann J.
        • Kuper M.A.
        • Maier I.B.
        • Spruss A.
        • Konigsrainer A.
        • et al.
        A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study.
        Eur J Nutr. 2013; 52: 527-535
        • Chiu S.
        • Sievenpiper J.
        • De Souza R.
        • Cozma A.
        • Mirrahimi A.
        • Carleton A.
        • et al.
        Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials.
        Eur J Clin Nutr. 2014; 68: 416
        • Chung M.
        • Ma J.
        • Patel K.
        • Berger S.
        • Lau J.
        • Lichtenstein A.H.
        Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.
        Am J Clin Nutr. 2014; 100: 833-849
        • Johnston R.D.
        • Stephenson M.C.
        • Crossland H.
        • Cordon S.M.
        • Palcidi E.
        • Cox E.F.
        • et al.
        No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men.
        Gastroenterology. 2013; 145 (e2): 1016-1025
        • Gelli C.
        • Tarocchi M.
        • Abenavoli L.
        • Di Renzo L.
        • Galli A.
        • De Lorenzo A.
        Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
        World J Gastroenterol. 2017; 23: 3150-3162
        • Katsagoni C.N.
        • Georgoulis M.
        • Papatheodoridis G.V.
        • Fragopoulou E.
        • Ioannidou P.
        • Papageorgiou M.
        • et al.
        Associations between lifestyle characteristics and the presence of nonalcoholic fatty liver disease: a case-control study.
        Metab Syndrome Relat Disord. 2017; 15: 72-79
        • Misciagna G.
        • Del Pilar Diaz M.
        • Caramia D.V.
        • Bonfiglio C.
        • Franco I.
        • Noviello M.R.
        • et al.
        Effect of a low glycemic index Mediterranean diet on non-alcoholic fatty liver disease. a randomized controlled clinici trial.
        J Nutr Health Aging. 2017; 21: 404-412
        • Perez-Guisado J.
        • Munoz-Serrano A.
        The effect of the Spanish ketogenic Mediterranean diet on nonalcoholic fatty liver disease: a pilot study.
        J Med Food. 2011; 14: 677-680
        • Ryan M.C.
        • Itsiopoulos C.
        • Thodis T.
        • Ward G.
        • Trost N.
        • Hofferberth S.
        • et al.
        The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease.
        J Hepatol. 2013; 59: 138-143
        • Shai I.
        • Schwarzfuchs D.
        • Henkin Y.
        • Shahar D.R.
        • Witkow S.
        • Greenberg I.
        • et al.
        Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.
        N Engl J Med. 2008; 359: 229-241
        • Trovato F.M.
        • Catalano D.
        • Martines G.F.
        • Pace P.
        • Trovato G.M.
        Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.
        Clin Nutr. 2015; 34: 86-88
        • Aller R.
        • Izaola O.
        • de la Fuente B.
        • De Luis Roman D.A.
        Mediterranean diet is associated with liver histology in patients with non alcoholic fatty liver disease.
        Nutr Hosp. 2015; 32: 2518-2524
        • Della Corte C.
        • Mosca A.
        • Vania A.
        • Alterio A.
        • Iasevoli S.
        • Nobili V.
        Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: the results of an Italian study.
        Nutrition. 2017; 39–40: 8-14
        • Kontogianni M.D.
        • Tileli N.
        • Margariti A.
        • Georgoulis M.
        • Deutsch M.
        • Tiniakos D.
        • et al.
        Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease.
        Clin Nutr. 2014; 33: 678-683
        • Trovato F.M.
        • Martines G.F.
        • Brischetto D.
        • Trovato G.
        • Catalano D.
        Neglected features of lifestyle: their relevance in non-alcoholic fatty liver disease.
        World J Hepatol. 2016; 8: 1459-1465
        • Tzima N.
        • Pitsavos C.
        • Panagiotakos D.B.
        • Chrysohoou C.
        • Polychronopoulos E.
        • Skoumas J.
        • et al.
        Adherence to the Mediterranean diet moderates the association of aminotransferases with the prevalence of the metabolic syndrome; the ATTICA study.
        Nutr Metabol (Lond). 2009; 6: 30
        • Abenavoli L.
        • Milic N.
        • Peta V.
        • Alfieri F.
        • De Lorenzo A.
        • Bellentani S.
        Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.
        World J Gastroenterol. 2014; 20: 16831-16840
        • Suarez M.
        • Boque N.
        • Del Bas J.M.
        • Mayneris-Perxachs J.
        • Arola L.
        • Caimari A.
        Mediterranean diet and multi-ingredient-based interventions for the management of non-alcoholic fatty liver disease.
        Nutrients. 2017; 9
        • Velasco N.
        • Contreras A.
        • Grassi B.
        The Mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease.
        Curr Opin Clin Nutr Metabol Care. 2014; 17: 453-457
        • Gepner Y.
        • Shelef I.
        • Schwarzfuchs D.
        • Zelicha H.
        • Tene L.
        • Yaskolka Meir A.
        • et al.
        Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial.
        Circulation. 2018; 137: 1143-1157
        • Ma J.
        • Hennein R.
        • Liu C.
        • Long M.T.
        • Hoffmann U.
        • Jacques P.F.
        • et al.
        Improved diet quality associates with reduction in liver fat, particularly in individuals with high genetic risk scores for nonalcoholic fatty liver disease.
        Gastroenterology. 2018; 155: 107-117
        • Papamiltiadous E.S.
        • Roberts S.K.
        • Nicoll A.J.
        • Ryan M.C.
        • Itsiopoulos C.
        • Salim A.
        • et al.
        A randomised controlled trial of a Mediterranean dietary intervention for adults with non alcoholic fatty liver disease (MEDINA): study protocol.
        BMC Gastroenterol. 2016; 16: 14
        • Rehm J.
        • Taylor B.
        • Mohapatra S.
        • Irving H.
        • Baliunas D.
        • Patra J.
        • et al.
        Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis.
        Drug Alcohol Rev. 2010; 29: 437-445
        • VanWagner L.B.
        • Ning H.
        • Allen N.B.
        • Ajmera V.
        • Lewis C.E.
        • Carr J.J.
        • et al.
        Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease.
        Gastroenterology. 2017; 153 (e3): 1260-1272
        • Marciano F.
        • Savoia M.
        • Vajro P.
        Celiac disease-related hepatic injury: insights into associated conditions and underlying pathomechanisms.
        Dig Liver Dis. 2016; 48: 112-119
        • Ludvigsson J.F.
        • Elfstrom P.
        • Broome U.
        • Ekbom A.
        • Montgomery S.M.
        Celiac disease and risk of liver disease: a general population-based study.
        Clin Gastroenterol Hepatol. 2007; 5 (e1): 63-69
        • Rubio-Tapia A.
        • Murray J.A.
        The liver in celiac disease.
        Hepatology. 2007; 46: 1650-1658
        • Volta U.
        Pathogenesis and clinical significance of liver injury in celiac disease.
        Clin Rev Allergy Immunol. 2009; 36: 62-70
        • Volta U.
        • De Franceschi L.
        • Lari F.
        • Molinaro N.
        • Zoli M.
        • Bianchi F.B.
        Coeliac disease hidden by cryptogenic hypertransaminasaemia.
        Lancet. 1998; 352: 26-29
        • Zippelius A.
        • Diebold J.
        Images in hepatology. Steatosis hepatis in celiac disease.
        J Hepatol. 1999; 30: 531
        • Abdo A.
        • Meddings J.
        • Swain M.
        Liver abnormalities in celiac disease.
        Clin Gastroenterol Hepatol. 2004; 2: 107-112
        • Bardella M.T.
        • Vecchi M.
        • Conte D.
        • Del Ninno E.
        • Fraquelli M.
        • Pacchetti S.
        • et al.
        Chronic unexplained hypertransaminasemia may be caused by occult celiac disease.
        Hepatology. 1999; 29: 654-657
        • Wakim-Fleming J.
        • Pagadala M.R.
        • McCullough A.J.
        • Lopez R.
        • Bennett A.E.
        • Barnes D.S.
        • et al.
        Prevalence of celiac disease in cirrhosis and outcome of cirrhosis on a gluten free diet: a prospective study.
        J Hepatol. 2014; 61: 558-563
        • Reilly N.R.
        • Lebwohl B.
        • Hultcrantz R.
        • Green P.H.
        • Ludvigsson J.F.
        Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease.
        J Hepatol. 2015; 62: 1405-1411
        • Duggan J.M.
        • Duggan A.E.
        Systematic review: the liver in coeliac disease.
        Aliment Pharmacol Ther. 2005; 21: 515-518
        • Arslan N.
        • Buyukgebiz B.
        • Ozturk Y.
        • Ozer E.
        The prevalence of liver function abnormalities in pediatric celiac disease patients and its relation with intestinal biopsy findings.
        Acta Gastroenterol Belg. 2005; 68: 424-427
        • Bardella M.T.
        • Fraquelli M.
        • Quatrini M.
        • Molteni N.
        • Bianchi P.
        • Conte D.
        Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet.
        Hepatology. 1995; 22: 833-836
        • Bonamico M.
        • Pitzalis G.
        • Culasso F.
        • Vania A.
        • Monti S.
        • Benedetti C.
        • et al.
        Hepatic damage in celiac disease in children.
        Minerva Pediatr. 1986; 38: 959-962
        • Christl S.
        • Müller J.
        Fettleber bei adulter Sprue.
        DMW-Deutsche Medizinische Wochenschrift. 1999; 124: 691-694
        • Hagander B.
        • Berg N.O.
        • Brandt L.
        • Norden A.
        • Sjolund K.
        • Stenstam M.
        Hepatic injury in adult coeliac disease.
        Lancet. 1977; 2: 270-272
        • Jacobsen M.B.
        • Fausa O.
        • Elgjo K.
        • Schrumpf E.
        Hepatic lesions in adult coeliac disease.
        Scand J Gastroenterol. 1990; 25: 656-662
        • Novacek G.
        • Miehsler W.
        • Wrba F.
        • Ferenci P.
        • Penner E.
        • Vogelsang H.
        Prevalence and clinical importance of hypertransaminasaemia in coeliac disease.
        Eur J Gastroenterol Hepatol. 1999; 11: 283-288
        • Kaukinen K.
        • Halme L.
        • Collin P.
        • Farkkila M.
        • Maki M.
        • Vehmanen P.
        • et al.
        Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure.
        Gastroenterology. 2002; 122: 881-888
        • Bugianesi E.
        • Gentilcore E.
        • Manini R.
        • Natale S.
        • Vanni E.
        • Villanova N.
        • et al.
        A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
        Am J Gastroenterol. 2005; 100: 1082-1090
        • Dufour J.F.
        • Oneta C.M.
        • Gonvers J.J.
        • Bihl F.
        • Cerny A.
        • Cereda J.M.
        • et al.
        Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis.
        Clin Gastroenterol Hepatol. 2006; 4: 1537-1543
        • Harrison S.A.
        • Torgerson S.
        • Hayashi P.
        • Ward J.
        • Schenker S.
        Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.
        Am J Gastroenterol. 2003; 98: 2485-2490
        • Hasegawa T.
        • Yoneda M.
        • Nakamura K.
        • Makino I.
        • Terano A.
        Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.
        Aliment Pharmacol Ther. 2001; 15: 1667-1672
        • Kugelmas M.
        • Hill D.B.
        • Vivian B.
        • Marsano L.
        • McClain C.J.
        Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.
        Hepatology. 2003; 38: 413-419
        • Lavine J.E.
        • Schwimmer J.B.
        • Van Natta M.L.
        • Molleston J.P.
        • Murray K.F.
        • Rosenthal P.
        • et al.
        Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
        JAMA. 2011; 305: 1659-1668
        • Magosso E.
        • Ansari M.A.
        • Gopalan Y.
        • Shuaib I.L.
        • Wong J.W.
        • Khan N.A.
        • et al.
        Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial.
        Nutr J. 2013; 12: 166
        • Sanyal A.J.
        • Chalasani N.
        • Kowdley K.V.
        • McCullough A.
        • Diehl A.M.
        • Bass N.M.
        • et al.
        Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
        N Engl J Med. 2010; 362: 1675-1685
        • Sanyal A.J.
        • Mofrad P.S.
        • Contos M.J.
        • Sargeant C.
        • Luketic V.A.
        • Sterling R.K.
        • et al.
        A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis.
        Clin Gastroenterol Hepatol. 2004; 2: 1107-1115
        • Yakaryilmaz F.
        • Guliter S.
        • Savas B.
        • Erdem O.
        • Ersoy R.
        • Erden E.
        • et al.
        Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.
        Intern Med J. 2007; 37: 229-235
        • Hoofnagle J.H.
        • Van Natta M.L.
        • Kleiner D.E.
        • Clark J.M.
        • Kowdley K.V.
        • Loomba R.
        • et al.
        Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.
        Aliment Pharmacol Ther. 2013; 38: 134-143
        • Miller 3rd, E.R.
        • Pastor-Barriuso R.
        • Dalal D.
        • Riemersma R.A.
        • Appel L.J.
        • Guallar E.
        Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.
        Ann Intern Med. 2005; 142: 37-46
        • Bjelakovic G.
        • Gluud L.L.
        • Nikolova D.
        • Bjelakovic M.
        • Nagorni A.
        • Gluud C.
        Meta-analysis: antioxidant supplements for liver diseases – the cochrane hepato-biliary group.
        Aliment Pharmacol Ther. 2010; 32: 356-367
        • Musso G.
        • Gambino R.
        • Cassader M.
        • Pagano G.
        A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease.
        Hepatology. 2010; 52: 79-104
        • Ji H.F.
        • Sun Y.
        • Shen L.
        Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
        Nutrition. 2014; 30: 986-991
        • Chachay V.S.
        • Macdonald G.A.
        • Martin J.H.
        • Whitehead J.P.
        • O'Moore-Sullivan T.M.
        • Lee P.
        • et al.
        Resveratrol does not benefit patients with nonalcoholic fatty liver disease.
        Clin Gastroenterol Hepatol. 2014; 12 (e1-6): 2092-2103
        • Chen S.
        • Zhao X.
        • Ran L.
        • Wan J.
        • Wang X.
        • Qin Y.
        • et al.
        Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
        Dig Liver Dis. 2015; 47: 226-232
        • Faghihzadeh F.
        • Adibi P.
        • Hekmatdoost A.
        The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
        Br J Nutr. 2015; 114: 796-803
        • Faghihzadeh F.
        • Adibi P.
        • Rafiei R.
        • Hekmatdoost A.
        Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
        Nutr Res. 2014; 34: 837-843
        • Guo H.
        • Zhong R.
        • Liu Y.
        • Jiang X.
        • Tang X.
        • Li Z.
        • et al.
        Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease.
        Nutrition. 2014; 30: 198-203
        • Zhang P.W.
        • Chen F.X.
        • Li D.
        • Ling W.H.
        • Guo H.H.
        A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.
        Medicine (Baltimore). 2015; 94: e758
        • Farhangi M.A.
        • Alipour B.
        • Jafarvand E.
        • Khoshbaten M.
        Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
        Arch Med Res. 2014; 45: 589-595
        • Ipsen D.H.
        • Tveden-Nyborg P.
        • Lykkesfeldt J.
        Does vitamin C deficiency promote fatty liver disease development?.
        Nutrients. 2014; 6: 5473-5499
        • Buchman A.L.
        The addition of choline to parenteral nutrition.
        Gastroenterology. 2009; 137: S119-S128
        • Guerrerio A.L.
        • Colvin R.M.
        • Schwartz A.K.
        • Molleston J.P.
        • Murray K.F.
        • Diehl A.
        • et al.
        Choline intake in a large cohort of patients with nonalcoholic fatty liver disease.
        Am J Clin Nutr. 2012; 95: 892-900
        • Yu D.
        • Shu X.O.
        • Xiang Y.B.
        • Li H.
        • Yang G.
        • Gao Y.T.
        • et al.
        Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.
        J Nutr. 2014; 144: 2034-2040
        • Imajo K.
        • Fujita K.
        • Yoneda M.
        • Shinohara Y.
        • Suzuki K.
        • Mawatari H.
        • et al.
        Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: a multi-center validation study.
        Hepatol Res. 2012; 42: 757-766
        • Malaguarnera M.
        • Gargante M.P.
        • Russo C.
        • Antic T.
        • Vacante M.
        • Malaguarnera M.
        • et al.
        L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial.
        Am J Gastroenterol. 2010; 105: 1338-1345
        • Bae J.C.
        • Lee W.Y.
        • Yoon K.H.
        • Park J.Y.
        • Son H.S.
        • Han K.A.
        • et al.
        Improvement of nonalcoholic fatty liver disease with carnitine-orotate complex in type 2 diabetes (CORONA): a randomized controlled trial.
        Diabetes Care. 2015; 38: 1245-1252
        • Simopoulos A.P.
        Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease.
        Nutrients. 2013; 5: 2901-2923
        • Scorletti E.
        • Bhatia L.
        • McCormick K.G.
        • Clough G.F.
        • Nash K.
        • Hodson L.
        • et al.
        Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
        Hepatology. 2014; 60: 1211-1221
        • Sanyal A.J.